Beijing Jishuitan Hospital
Clinical trials sponsored by Beijing Jishuitan Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a collagen patch fix elbow cartilage better than surgery alone? Results expected Dec 2026 (estimated)
-
Can tiny stem cell packages rescue a dying hip?
Disease control Not yet recruitingThis early-stage trial is testing whether a single injection of stem cell-derived exosomes into the hip joint is safe and might help people with non-traumatic osteonecrosis of the femoral head, a condition where the hip bone loses blood supply and begins to collapse. The study wi…
Early phase 1 • Sponsor: Beijing Jishuitan Hospital • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a collagen patch fix elbow cartilage better than surgery alone?
Disease control Not yet recruitingThis study tests whether adding a collagen scaffold during elbow surgery helps repair damaged cartilage better than surgery alone. Ninety adults aged 18 to 55 with elbow cartilage defects will be randomly assigned to receive either microfracture surgery plus the scaffold or just …
Phase 3 • Sponsor: Beijing Jishuitan Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:15 UTC
-
New study aims to stop frozen shoulder after common surgery
Symptom relief Not yet recruitingThis study looks at whether doing extra tissue release during arthroscopic rotator cuff repair can prevent shoulder stiffness after surgery. About 50 adults with small-to-medium rotator cuff tears will be randomly assigned to get either the standard repair or the repair plus extr…
Sponsor: Beijing Jishuitan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC